Top Markets
#1 OSK OSK +15.45%
#2 Ardor Ardor +7.80%
#3 MarsCoin MarsCoin +7.36%
#4 Tornado Cash Tornado Cash +6.57%
#5 HOME HOME +5.86%
#6 Nesa Nesa +5.10%
#7 UnifAI Network UnifAI Network +4.33%
#8 AI XOVIA AI XOVIA +4.25%
#9 Cash Cat Cash Cat +4.14%
#10 Biconomy Biconomy +4.03%
Coin of the day
OSK OSK
Настройки
Язык
Pусский
Валюта
USD
Тема
Carvolix S.A. Carvolix S.A.

Carvolix S.A.

CVX
Ранг среди акций #16560
Carvolix S.A. operates as a medical technology firm, concurrently involved in... Carvolix S.A. operates as a medical technology firm, concurrently involved in both commercialization and clinical development, specializing in treatment solutions for structural heart ailments and cerebral strokes. The company's innovative endeavors encompass the creation of AI- and imaging-driven mini-robots, engineered for executing intricate medical procedures, as well as the development of biomimetic heart valves. Established on January 30, 2026, Carvolix S.A. maintains its headquarters in Aix-en-Provence, France.
Цена акции
$7.31
Последняя синхронизация: 2026-09-01
Рыночная капитализация
$286.87M
Изменение (1 день)
-1.91%
Изменение (1 год)
310.35%
Страна
FR
Торговля Carvolix S.A. (CVX)

Категория

Healthcare
Коэффициент P/S для Carvolix S.A. (CVX)
Коэффициент P/S на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Carvolix S.A., текущий коэффициент P/S (TTM) составляет 0. В конце 2026 он составлял 0.
История P/S для Carvolix S.A. с 2026 по 2026
Коэффициент P/S в конце каждого года
Год P/S Изменить
Недостаточно данных для указанных дат.
Коэффициент P/S для аналогичных компаний или конкурентов
Компания P/S Разница P/S Страна
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.10 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
4.80 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.42 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.02 -
US